EPISODE · Nov 18, 2024 · 3 MIN
FDA D.I.S.C.O. Burst Edition: FDA approval of Tecelra (afamitresgene autoleucel) for unresectable or metastatic synovial sarcoma
from FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) · host U.S. Food and Drug Administration, Center for Drug Evaluation and Research
Listen to a soundcast of the 8.2.2024 FDA approval of Tecelra (afamitresgene autoleucel) for unresectable or metastatic synovial sarcoma.
NOW PLAYING
FDA D.I.S.C.O. Burst Edition: FDA approval of Tecelra (afamitresgene autoleucel) for unresectable or metastatic synovial sarcoma
No transcript for this episode yet
Similar Episodes
Apr 26, 2026 ·35m
Apr 25, 2026 ·141m
Apr 24, 2026 ·55m
Apr 23, 2026 ·54m
Apr 22, 2026 ·40m
Apr 21, 2026 ·64m